IDO1 and neoplasm: In tumor‐draining lymph nodes (TDLN), antigen‐presenting cells (APCs, such as dendritic cells) inherently expressing IDO1 induce iTregs, suppress T effector cells (Teffs), and result in systemic tumor immune suppression [28].